PPT-Ready to Patent? Value and Risk Considerations

Nicolo Davidson Forbes 2014 Baby Patting Machine US Patent No 3552388 Portable Automobile Partition US Patent No 6260903 Valuation Market Freedom t o Operate Risks Scope. The Seldom-Used “Simultaneous Invention” Factor By Brent Yamashita of DLA Piper US LLP Introduction In nearly every patent litigation, the accused claims are obvious (if not anticipated) b the Early Development Instrument. Developed in Canada in 1998 and expanding across US since 2009 through the TECCS network. Population-based (results for neighborhoods and schools but not individual children). VALUES . DECLINING. ?. GREY . GOLD . ADVISORS, LLC Wild Dunes 2015. Is the US ANTI PATENT?. Hard to Stop . Infringers. Damages Decline. Patent Litigation is Expensive. Patent Win Rates are Low. PTO Invalidates Contested Patents. Intellectual Property Litigation for the Non-Litigator. June 2013. Table of Contents. 1. Overview ..................................................................................................................... Recent Trends and Insurance Considerations. March 2015. www.pwc.com. – . 2. March 2015. Cyber Risk. – Recent Trends and Insurance Considerations . Cyber Risk – Recent Trends and Insurance Considerations . VALUES . DECLINING. ?. GREY . GOLD . ADVISORS, LLC Wild Dunes 2015. Is the US ANTI PATENT?. Hard to Stop . Infringers. Damages Decline. Patent Litigation is Expensive. Patent Win Rates are Low. PTO Invalidates Contested Patents. pharma. or bad patents?. Inefficiencies through the patent protection process. Return to patent protection rewards . pharma. profits. Marketing same level as . pharma. R&D. Government regulation costly. Intellectual Property Litigation for the Non-Litigator. June 2013. Table of Contents. 1. Overview ..................................................................................................................... . Association . of Corporate Counsel. © 2015. 1. Our . questions…. 2. "What should my company do to prepare for a data-related . incident?". "What can I do to . help manage risks while supporting innovation?”. Team. . UNC. 1/29/2016. Agenda. Executive Summary. Choosing 7 year . p. atent over 10 year data protection has great benefits but need to overcome risks. Composition patent. 5 year data protection. Patent power: Prevent sales loss by protecting large US market. Team. . UNC. 1/29/2016. Agenda. Executive Summary. Choosing 7 year . p. atent over 10 year data protection has great benefits but need to overcome risks. Composition patent. 5 year data protection. Patent power: Prevent sales loss by protecting large US market. December 6, 2018 Advanced Patent Law Institute Palo Alto Obviousness: Latest Developments Steven Carlson Robins Kaplan LLP Derek Walter Weil Gotshal & Manges LLP 2 Roadmap Serial IPRs Broadest Reasonable Interpretation v. Bruno van Pottelsberghe de la Potterie The Quality Factor in Patent Systems Vienna PATSTAT Conference 2010 Seite 2 von 5 II CRITERIA OF PATENT QUALITY - DPMA APPROACH 5 In order to gain a clearer und ASMA 2021 #4233. Jon G. Steller, MD; Rebecca S. Blue, MD, MPH; Roshan Burns, BS; Tina M. Bayuse, PharmD; Erik L. . Antonsen. , MD, PhD; Varsha Jain, MD; Michele M. Blackwell, MD. ;. Richard T. Jennings, MD, MS.